How Much Does Methimazole (Tapazole) Cost in Hawaii in 2026?

Hawaii Cash Prices for Methimazole in 2026

The average cash-pay price for generic methimazole at Hawaii retail pharmacies sits around $15 per month in 2026. That figure covers a standard 30-tablet supply of 5 mg or 10 mg tablets. Brand-name Tapazole, manufactured by Pfizer, carries a list price near $80 per month, but very few patients pay this amount because generics are widely stocked at every major Hawaii chain pharmacy, including CVS, Longs Drugs, Walgreens, and Walmart.

Price variation exists across the islands. Pharmacies on Oahu typically post prices within $2 to $3 of the state average due to competition density. Neighbor island pharmacies on Maui, Kauai, and the Big Island may charge slightly more because of shipping costs and smaller patient volumes. A 2024 analysis of Medicare Part D spending found that antithyroid drugs like methimazole ranked among the lowest-cost chronic medications nationally, with median out-of-pocket costs under $10 per fill for insured beneficiaries 1. Checking prices at two or three pharmacies before filling can save $5 to $10 per month, especially outside Honolulu.

The Cooper 2005 review in the New England Journal of Medicine established methimazole as the preferred first-line antithyroid drug over propylthiouracil (PTU) for most adults with Graves' disease, citing a more favorable side-effect profile and once-daily dosing convenience 1. This recommendation from the American Thyroid Association (ATA) persists in 2026, which means methimazole demand remains consistent and generic competition keeps prices low.

Hawaii Medicaid Does Not Cover Methimazole

Hawaii's Medicaid program, known as Med-QUEST, does not include methimazole on its preferred drug list as of 2026. This gap affects roughly 400,000 Med-QUEST enrollees statewide. Patients relying on Medicaid for hyperthyroidism treatment face the full cash-pay cost unless they pursue alternatives.

Three options exist for Med-QUEST members who need methimazole. First, prescribers can submit a prior authorization (PA) request. Hawaii Med-QUEST allows PA for drugs not on the formulary if the prescriber documents medical necessity, including failed trials of covered alternatives or clinical contraindications 2. Second, patients can use manufacturer or pharmacy discount programs that may bring the cost below even the Medicaid copay threshold. Third, switching to PTU is possible for some patients, though the ATA recommends methimazole as first-line in non-pregnant adults due to lower hepatotoxicity risk.

Dr. David Cooper, writing in the New England Journal of Medicine, noted that "methimazole is preferred over propylthiouracil for the treatment of Graves' hyperthyroidism in virtually all patients except during the first trimester of pregnancy" 1. This clinical preference makes the Medicaid gap particularly frustrating for Hawaii patients with Graves' disease.

Enrollees should contact their Med-QUEST health plan directly. AlohaCare, HMSA, Kaiser Permanente Hawaii, Ohana Health Plan, and UnitedHealthcare Community Plan each administer Med-QUEST benefits and may have different PA processing times and criteria.

Commercial Insurance Coverage Across Hawaii

Most commercial health plans in Hawaii cover generic methimazole on their lowest formulary tier. HMSA, the state's largest private insurer covering over 700,000 members, lists methimazole as a Tier 1 generic with copays typically between $5 and $15 per fill. Kaiser Permanente Hawaii covers methimazole through its integrated pharmacy system with similar cost-sharing.

Hawaii's Prepaid Health Care Act, the only state-mandated employer health insurance law in the country, requires employers to provide coverage for employees working 20 or more hours per week. This means a larger share of Hawaii's workforce has prescription drug coverage compared to most mainland states. For these insured workers, methimazole copays rarely exceed $15 per month.

Patients with high-deductible health plans (HDHPs) pay cash prices until meeting their deductible. At $15 per month for generic methimazole, even HDHP members face a manageable expense. The ATA's 2016 guidelines for hyperthyroidism management recommend treatment courses of 12 to 18 months for Graves' disease, making total out-of-pocket exposure between $180 and $270 at Hawaii cash prices 3.

Brand-name Tapazole may require Tier 2 or Tier 3 copays, ranging from $25 to $50 per fill. Because the generic is bioequivalent and dramatically cheaper, few clinical situations justify brand-name prescribing. If a prescriber writes "dispense as written" for Tapazole, patients should ask whether the generic would be equally appropriate.

Discount Programs and Savings Cards

Several discount programs reduce methimazole costs for uninsured or underinsured Hawaii residents. These tools work at most Hawaii pharmacies and require no insurance.

GoodRx and RxSaver coupons typically bring generic methimazole below $10 for a 30-day supply at Costco (Iwilei and Maui locations), Walmart, and some independent pharmacies. Prices fluctuate weekly, so checking the day before refilling is worth the effort. Mark Cuban's Cost Plus Drugs (costplusdrugs.com) offers methimazole at cost-plus-15% with a flat pharmacy fee, and ships to Hawaii addresses.

Pfizer does not operate a standalone savings card specifically for Tapazole, but its Pfizer Patient Assistance Program covers uninsured patients with household incomes below 400% of the federal poverty level. Qualifying Hawaii residents can receive brand-name Tapazole at no cost through this program. Application requires prescriber involvement and income documentation.

NeedyMeds and RxAssist maintain databases of patient assistance programs applicable to Hawaii residents. The 340B Drug Pricing Program also extends discounted pricing at federally qualified health centers (FQHCs) across Hawaii, including Waikiki Health, Kalihi-Palama Health Center, Waianae Coast Comprehensive Health Center, and Bay Clinic on the Big Island. Patients seen at these FQHCs may access methimazole at deeply reduced prices regardless of insurance status 4.

Compounded Methimazole Through 503A Pharmacies

Compounded methimazole is legal and available in Hawaii through licensed 503A compounding pharmacies. A 503A pharmacy compounds medications pursuant to individual patient prescriptions under state board of pharmacy oversight.

Compounding serves patients who cannot tolerate standard tablet formulations. Methimazole tablets contain inactive ingredients (lactose, starch, magnesium stearate) that some patients react to. Compounded methimazole can be prepared as a lactose-free capsule, liquid suspension, or flavored oral solution. Pediatric patients and those with swallowing difficulties benefit most from compounded formulations.

Hawaii has a limited number of compounding pharmacies compared to mainland states. Clinical Compounding Pharmacy in Honolulu and a small number of other licensed compounders fill methimazole prescriptions. Compounded pricing varies widely based on formulation complexity, dose strength, and preparation type, but some 503A pharmacies in Hawaii have been noted to offer compounded methimazole at very competitive prices.

Patients should confirm that their compounding pharmacy holds a current Hawaii Board of Pharmacy license and operates under 503A (not 503B outsourcing facility) regulations. Prescribers must write the prescription specifically for the compounded product, and the prescription cannot be a copy of a commercially available formulation without a documented clinical reason for compounding 5.

Telehealth Access to Methimazole Prescriptions in Hawaii

Hawaii permits telehealth prescribing of methimazole. Patients can obtain new prescriptions and refills through video or audio visits with licensed prescribers without an in-person office visit. This is particularly valuable for neighbor island residents who may live hours from an endocrinologist.

Hawaii had only 21 practicing endocrinologists per the 2024 HRSA Area Health Resource File, concentrated almost entirely on Oahu. Residents of Molokai, Lanai, and rural areas of the Big Island and Maui face significant travel burdens for in-person thyroid care. Telehealth eliminates this barrier for methimazole management.

The standard monitoring protocol for methimazole requires complete blood count (CBC) and liver function tests (LFTs) at baseline and periodically during treatment 1. Thyroid function tests (TSH, free T4, total T3) are checked every 4 to 6 weeks initially, then every 2 to 3 months once stable. These labs can be drawn at any Quest Diagnostics, Clinical Labs of Hawaii, or hospital lab and results transmitted to the telehealth prescriber.

HealthRX offers telehealth consultations for thyroid-related prescriptions in Hawaii. The process typically involves an initial evaluation, lab review, prescription issuance to a Hawaii pharmacy of the patient's choice, and ongoing monitoring visits at intervals set by the treating clinician. Patients can start treatment without leaving their island.

Methimazole Dosing and Treatment Duration

The FDA-approved starting dose of methimazole for Graves' hyperthyroidism ranges from 15 mg to 30 mg daily in moderate-to-severe cases, with 5 mg to 10 mg daily for mild disease 6. Most patients take a single daily dose, a significant convenience advantage over PTU, which requires two or three daily doses. After 4 to 8 weeks, the dose is titrated down to a maintenance range of 5 to 10 mg daily based on thyroid function tests.

A full treatment course typically lasts 12 to 18 months. The RISG study found that Graves' disease remission rates after a standard course of methimazole averaged 50% to 55%, with higher remission probability in patients with small goiters, mild biochemical hyperthyroidism, and negative or low thyrotropin receptor antibody (TRAb) titers at the end of treatment 7.

Cost over a full treatment course in Hawaii breaks down simply. At $15 per month for 18 months, a patient pays $270 total for the medication. Even without insurance, methimazole ranks among the most affordable chronic disease treatments available. Patients who achieve remission discontinue therapy entirely. Those who relapse may undergo a second course of methimazole or consider definitive therapy with radioactive iodine (RAI) or thyroidectomy.

The ATA 2016 guidelines state: "if a patient with Graves' disease has relapsed after an adequate course of antithyroid drugs, RAI therapy or thyroidectomy should be considered, although a second course of ATDs may be offered" 3.

Side Effects and Monitoring Costs to Consider

Methimazole side effects are uncommon but include rash (5% to 10% of patients), joint pain, gastrointestinal upset, and rare but serious agranulocytosis (0.2% to 0.5%) and hepatotoxicity 1. Monitoring labs add to the total cost of therapy.

A CBC with differential and a hepatic panel cost between $25 and $80 at Hawaii labs without insurance. Thyroid function panels (TSH, free T4, total T3) add $50 to $150 per draw at cash-pay rates. Over 18 months, a patient may need 6 to 10 lab draws, adding $450 to $1,500 in lab costs on top of medication expense.

Insured patients typically pay $0 to $30 per lab draw as a copay. Quest Diagnostics and Clinical Labs of Hawaii both accept most Hawaii insurance plans. Patients using telehealth should factor lab costs into their total treatment budget, particularly if they are paying cash for both visits and labs.

The FDA label for methimazole warns prescribers to instruct patients to report sore throat, fever, mouth ulcers, or signs of infection immediately, as these may indicate agranulocytosis requiring emergent CBC testing 6. This safety monitoring is non-negotiable regardless of cost.

Comparing Methimazole to Alternatives in Hawaii

Methimazole is not the only treatment for hyperthyroidism, but it is the least expensive first-line option. RAI therapy costs $1,000 to $3,000 for the procedure itself, plus pre-treatment workup and post-treatment monitoring. Thyroidectomy costs $10,000 to $25,000 depending on surgeon, facility, and insurance negotiation. Both definitive therapies result in lifelong levothyroxine replacement (approximately $10 to $30 per month).

PTU, the other antithyroid drug, costs roughly the same as generic methimazole ($10 to $20 per month) but carries a higher risk of serious liver injury and requires multiple daily doses. The ATA recommends PTU only during the first trimester of pregnancy and in thyroid storm 3.

Beta-blockers like propranolol or atenolol are used as adjunctive therapy for symptom control (tremor, palpitations, anxiety) during the weeks before methimazole reaches full effect. Generic propranolol costs $4 to $10 per month in Hawaii. These are add-on costs, not alternatives to antithyroid therapy.

For Hawaii patients weighing their options, a full 18-month methimazole course at $270 total medication cost represents the lowest-expense pathway that preserves the thyroid gland and avoids surgery or radiation. Approximately half of patients will achieve lasting remission without needing further intervention.